SCHEMBL5556007

SCHEMBL5556007

CCCCNC(=O)OC1c2ccccc2OC(C(C)C)C(=O)N1Cc1ccc(N(C)C)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.39
MAPT P10636 1/20 0.39
HCRTR1 O43613 1/20 0.37
HCRTR2 O43614 1/20 0.37
MEN1 O00255 3/20 0.36
PDPK1 O15530 1/20 0.34
BCHE P06276 1/20 0.34
TSHR P16473 2/20 0.34
KCNA5 P22460 2/20 0.34
KCNH2 Q12809 1/20 0.34
GAA P10253 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
HDAC3 O15379 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC2 Q92769 1/20 0.34
HDAC8 Q9BY41 1/20 0.34
ALOX15 P16050 2/20 0.33
HPGD P15428 1/20 0.33
PSMB1 P20618 1/20 0.33
PSMB5 P28074 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5556226 0.90 LMNA (0.41) MAPTHCRTR1HCRTR2TSHRKCNA5
SCHEMBL5555802 0.89 HCRTR1 (0.38) KMT2AMAPTHCRTR1HCRTR2MEN1
SCHEMBL5556322 0.86 KMT2A (0.44) KMT2AMAPTHCRTR1HCRTR2MEN1
SCHEMBL5556238 0.78 KCNA5 (0.43) KMT2AMAPTHCRTR1HCRTR2TSHR
SCHEMBL5560808 0.77 KCNA5 (0.37) KMT2AMAPTHCRTR1HCRTR2MEN1
SCHEMBL5562883 0.76 ITGB2 (0.31) KMT2AMAPTMEN1GAAL3MBTL1
SCHEMBL5555488 0.76 LMNA (0.40) KMT2AMAPTHCRTR1HCRTR2MEN1
SCHEMBL5561784 0.73 BCHE (0.45) KMT2AMAPTMEN1BCHETSHR
SCHEMBL5560845 0.71 MAPT (0.40) MAPTKCNA5GAA
SCHEMBL5555549 0.70 HCRTR1 (0.40) KMT2AMAPTHCRTR1HCRTR2KCNA5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1631296-B1 2,3,4,5-TETRAHYDROBENZO¬F|¬1,4|OXAZEPINE-5-CARBOXYLIC ACID AMIDE DERIVATIVES AS GAMMA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE HOFFMANN LA ROCHE (CH) 2007-04-25 EP claimed